Lifecore Biomedical, Inc.LFCRNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank49
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P49
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -67.05% |
| Q2 2025 | 345.58% |
| Q1 2025 | 119.64% |
| Q4 2024 | -850.23% |
| Q3 2024 | -107.44% |
| Q2 2024 | 709.31% |
| Q1 2024 | -210.09% |
| Q4 2023 | 115.46% |
| Q3 2023 | -2962.13% |
| Q2 2023 | 98.23% |
| Q1 2023 | -554.23% |
| Q4 2022 | -113.71% |
| Q3 2022 | -3158.33% |
| Q2 2022 | 100.20% |
| Q1 2022 | -245.32% |
| Q4 2021 | -718.17% |
| Q3 2021 | -81.19% |
| Q2 2021 | 156.22% |
| Q1 2021 | -647.46% |
| Q4 2020 | -91.57% |
| Q3 2020 | 233.99% |
| Q2 2020 | -220.02% |
| Q1 2020 | 211.61% |
| Q4 2019 | -74.35% |
| Q3 2019 | -280.62% |
| Q2 2019 | -111.30% |
| Q1 2019 | 383.23% |
| Q4 2018 | 19.72% |
| Q3 2018 | 30.04% |
| Q2 2018 | -87.79% |
| Q1 2018 | 208.63% |
| Q4 2017 | 3505.34% |
| Q3 2017 | -102.13% |
| Q2 2017 | -65.19% |
| Q1 2017 | 1978.09% |
| Q4 2016 | -114.54% |
| Q3 2016 | -58.24% |
| Q2 2016 | 277.27% |
| Q1 2016 | 1.84% |
| Q4 2015 | 319.20% |